Safety of Concomitant Potassium-Sparing Diuretics in Angiotensin-Converting Enzyme Inhibitor Therapy in Severe Congestive Heart Failure

Enzyme Inhibitor ◽

Severe Congestive Heart Failure ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Safety of Concomitant Potassium-Sparing Diuretics in Angiotensin-Converting Enzyme Inhibitor Therapy in Severe Congestive Heart Failure

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199408000-00002 ◽

1994 ◽

Vol 24 (2) ◽

pp. 194-198 ◽

Cited By ~ 4

Author(s):

Jutta Bergler-Klein ◽

Heinz Sochor ◽

Hubert Pouleur ◽

Richard Pacher ◽

Gerold Porenta ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Severe Congestive Heart Failure ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Effects of angiotensin-converting enzyme inhibitor therapy on presence of late potentials detected using signal-averaged electrocardiography in patients with congestive heart failure

Coronary Artery Disease ◽

10.1097/00019501-199312000-00012 ◽

1993 ◽

Vol 4 (12) ◽

pp. 1109-1114 ◽

Cited By ~ 3

Author(s):

L. Vacek James ◽

R. Handlin Larry ◽

J. Beaufort Constance ◽

A. Koenig Calverna

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Late Potentials ◽

Converting Enzyme ◽

Angiotensin-Converting Enzyme Inhibitor Therapy for Congestive Heart Failure: Rationale, Results, and Current Recommendations

10.1007/978-1-4613-8315-4_23 ◽

1994 ◽

pp. 380-399

Author(s):

Barry M. Massie ◽

Thomas Amidon

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2004.08.048 ◽

2004 ◽

Vol 44 (10) ◽

pp. 2019-2026 ◽

Cited By ~ 109

Author(s):

Dennis M. McNamara ◽

Richard Holubkov ◽

Lisa Postava ◽

Karen Janosko ◽

Guy A. MacGowan ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Deletion Polymorphism ◽

Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

ACC Current Journal Review ◽

10.1016/j.accreview.2005.02.054 ◽

2005 ◽

Vol 14 (3) ◽

pp. 36-37

Author(s):

D.M. McNamara ◽

R. Holubkov ◽

L. Postava

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Deletion Polymorphism ◽

Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure

American Heart Journal ◽

10.1016/j.ahj.2004.11.011 ◽

2005 ◽

Vol 149 (5) ◽

pp. 938.e1-938.e7 ◽

Cited By ~ 6

Author(s):

Martine Blanchet ◽

Richard Sheppard ◽

Normand Racine ◽

Anique Ducharme ◽

Daniel Curnier ◽

...

Keyword(s):

Heart Failure ◽

Exercise Capacity ◽

Enzyme Inhibitor ◽

Submaximal Exercise ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Neurohumoral Activation

Comparison of angiotensin converting enzyme inhibitor with digoxin versus without digoxin for the treatment of congestive heart failure

Pathophysiology ◽

10.1016/0928-4680(94)90130-9 ◽

1994 ◽

Vol 1 ◽

pp. 53

Author(s):

M. Hamada ◽

H. Okayama ◽

Y. Shigematsu ◽

T. Kobayashi ◽

M. Mukai ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin‐converting enzyme inhibitor therapy

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.5361 ◽

2021 ◽

Author(s):

Elizabeth T. Mansi ◽

Eric S. Johnson ◽

Micah L. Thorp ◽

Alan S. Go ◽

Ming‐Sum Lee ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Diagnosis Codes ◽

Patients With Heart Failure

Chronic Therapy for Congestive Heart Failure with Benazepril HCl, a New Angiotensin Converting Enzyme Inhibitor

The American Journal of the Medical Sciences ◽

10.1097/00000441-199012000-00003 ◽

1990 ◽

Vol 300 (6) ◽

pp. 354-360 ◽

Cited By ~ 1

Author(s):

David M. Mirvis ◽

Jerald Insel ◽

Michael J. Boland ◽

Michael P. Cinquegrani ◽

Jamal K. Ghali ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Chronic Therapy

Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor

The American Journal of Cardiology ◽

10.1016/0002-9149(93)90241-4 ◽

1993 ◽

Vol 71 (3) ◽

pp. A21-A28 ◽

Cited By ~ 122

Author(s):

AndréA. van Vliet ◽

Ab J.M. Donker ◽

Jos J.P. Nauta ◽

Freek W.A. Verheugt

Keyword(s):

Heart Failure ◽

Low Dose ◽

Loop Diuretic ◽

Enzyme Inhibitor ◽

High Dose ◽

Converting Enzyme ◽